Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR | P10275 | 5/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14086825 | 1.00 | AR (1.00) | AR | |
| SCHEMBL3698441 | 1.00 | AR (1.00) | AR | |
| SCHEMBL12706742 | 0.92 | AR (0.85) | AR | |
| SCHEMBL14252926 | 0.92 | AR (0.85) | AR | |
| SCHEMBL12453355 | 0.91 | AR (0.83) | AR | |
| SCHEMBL10364518 | 0.91 | AR (0.83) | AR | |
| SCHEMBL2689756 | 0.91 | AR (1.00) | AR | |
| SCHEMBL16871452 | 0.91 | AR (1.00) | AR | |
| SCHEMBL12451560 | 0.91 | AR (0.83) | AR | |
| SCHEMBL14086827 | 0.91 | AR (0.83) | AR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2276496-B1 | THERAPEUTIC MODULATION OF OCULAR SURFACE LUBRICATION | UNIV CALIFORNIA (US) | 2019-07-10 | — | — | EP | claimed |
| US-9138457-B2 | Therapeutic modulation of ocular surface lubrication | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2015-09-22 | — | — | US | claimed |
| WO-2009137602-A1 | THERAPEUTIC MODULATION OF OCULAR SURFACE LUBRICATION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2009-11-12 | — | — | WO | claimed |
| EP-2276497-B1 | OPHTHALMIC DEVICE, AND METHOD OF USE THEREOF, FOR INCREASING OCULAR BOUNDARY LUBRICATION | UNIV CALIFORNIA (US) | 2020-04-22 | — | — | EP | disclosed |
| EP-2276496-B1 | THERAPEUTIC MODULATION OF OCULAR SURFACE LUBRICATION | UNIV CALIFORNIA (US) | 2019-07-10 | — | — | EP | disclosed |
| US-9682093-B2 | Compositions and methods for treating or preventing metabolic syndrome disorders | CHARLES R. DREW UNIVERSITY OF MEDICINE AND SCIENCE (US) | 2017-06-20 | — | — | US | disclosed |
| EP-2464375-B1 | PRG4 TREATMENT FOR INTERSTITIAL CYSTITIS | LUBRIS LLC (US) | 2017-06-14 | — | — | EP | disclosed |
| US-9493403-B2 | Treating androgen decline in aging male (ADAM)-associated conditions with SARMs | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2016-11-15 | — | — | US | disclosed |
| US-9493403-B2 | Treating androgen decline in aging male (ADAM)-associated conditions with SARMs | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2016-11-15 | — | — | US | disclosed |
| EP-2289503-B1 | Treating muscle wasting with selective androgen receptor modulators | UNIV TENNESSEE RES FOUNDATION (US) | 2016-06-29 | — | — | EP | disclosed |
| US-9138457-B2 | Therapeutic modulation of ocular surface lubrication | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2015-09-22 | — | — | US | disclosed |
| US-20070173546-A1 | Selective androgen receptor modulators and method of use thereof | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2007-07-26 | — | — | US | disclosed |
| WO-2007081696-A2 | TREATING ANDROGEN DECLINE IN AGING MALE (ADAM)-ASSOCIATED CONDITIONS WITH SARMS | GTX, INC. (US) | 2007-07-19 | — | — | WO | disclosed |
| US-20070161608-A1 | Selective androgen receptor modulators for treating muscle wasting | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2007-07-12 | — | — | US | disclosed |
| US-20070161608-A1 | Selective androgen receptor modulators for treating muscle wasting | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2007-07-12 | — | — | US | disclosed |
| US-20070123563-A1 | Selective androgen receptor modulators and method of use thereof | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2007-05-31 | — | — | US | disclosed |
| US-20070123563-A1 | Selective androgen receptor modulators and method of use thereof | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2007-05-31 | — | — | US | disclosed |
| US-7205437-B2 | Selective androgen receptor modulators | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2007-04-17 | — | — | US | disclosed |
| US-7205437-B2 | Selective androgen receptor modulators | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2007-04-17 | — | — | US | disclosed |
| US-20070066568-A1 | Treating renal disease, burns, wounds and spinal cord injury with selective androgen receptor modulators | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2007-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070173546-A1 | Selective androgen receptor modulators and method of use thereof | AR, SHBG, ESRRA | AR 1/4885 |
| US-20070066568-A1 | Treating renal disease, burns, wounds and spinal cord injury with selective androgen receptor modulators | AR, SARM1, OPRM1 | AR 1/4885 |
| US-20070123563-A1 | Selective androgen receptor modulators and method of use thereof | AR, SHBG, ESRRA | AR 1/4885 |
| US-20070161608-A1 | Selective androgen receptor modulators for treating muscle wasting | AR, ESRRA, SHBG | AR 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.